Pharmacyclics files for OK of cancer drug
December 22nd, 2006
Pharmacyclics said Friday it submitted a new drug application with the U.S. Food and Drug Administration for Xcytrin.The company is seeking an indication for treatment of patients with non-small cell lung cancer that has metastasized to the brain.